Related Experiment Video
Updated: Aug 29, 2025

Visualization of SARS-CoV-2 using Immuno RNA-Fluorescence In Situ Hybridization
Published on: December 23, 2020
Implications at the ocular level of miRNAs modifications induced by SARS-CoV-2 infection
Adina Iuliana Milcu1, Andrei Anghel, Ovidiu Muşat
1Department of Biochemistry, Victor Babeş University of Medicine and Pharmacy, Timişoara, Romania; e-mail: biochim@umft.ro; Department of Ophthalmology, Dr. Carol Davila Central Military Emergency University Hospital, Bucharest, Romania; ovidiumusat@yahoo.com.
Abstract:
The coronavirus disease 2019 (COVID-19) pandemic determined the use of different research methods and investigations in the management of this novel infectious disease. The impact and development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at cellular level is still a challenge and many directions of investigation have been opened, a complex topic that has been explored is the bidirectional interaction between host micro-ribonucleic acids (miRNAs) and viral miRNA. The main point of this study is to analyze the transcriptional modifications induced by the viral infection at ocular level, mediated by miRNAs. It is known that the ocular transmission is a route of infection, and it can cause multiple neuro-ophthalmological manifestations, such as optic nerve dysfunction, eye movement abnormalities, oscillopsia and intracranial hypertension. We have managed to identify more than six miRNAs specifically involved in eye disorders that are strongly dysregulated by the SARS-CoV-2. These miRNAs regulate different pathways, such as the nuclear factor-kappa B (NF-κB) pathway, the expression of complement factor H (CFH) gene, the expression of transforming growth factor-beta (TGF-β), fibroblast growth factor (FGF) and platelet-derived growth factor (PDGF) genes. In the context of SARS-CoV-2 infection, many more molecular changes at ocular level need to be elucidated to better understanding the COVID-19.
Insights
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) dysregulates microRNAs (miRNAs) in the eye, impacting ocular tissues. This study identifies specific miRNAs involved in COVID-19-related eye disorders and their regulated pathways.
Area of Science:
- Ophthalmology
- Virology
- Molecular Biology
- Genetics
Background:
- The COVID-19 pandemic highlights the need for research into SARS-CoV-2's cellular impact.
- Host-viral microRNA interactions are complex and under investigation.
- Ocular transmission of SARS-CoV-2 can lead to neuro-ophthalmological issues.
Purpose of the Study:
- To analyze SARS-CoV-2-induced transcriptional modifications in ocular tissues mediated by microRNAs (miRNAs).
- To identify specific miRNAs dysregulated in the eye due to SARS-CoV-2 infection.
- To understand the role of these miRNAs in COVID-19-related ocular manifestations.
Main Methods:
- Analysis of transcriptional modifications in ocular tissues.
- Identification of specific microRNAs (miRNAs) dysregulated by SARS-CoV-2.
- Investigation of miRNA-regulated pathways.
Main Results:
- Over six specific miRNAs involved in eye disorders were identified as dysregulated by SARS-CoV-2.
- These miRNAs regulate key pathways including NF-κB, CFH, TGF-β, FGF, and PDGF.
- SARS-CoV-2 infection significantly alters miRNA expression in ocular tissues.
Conclusions:
- SARS-CoV-2 infection induces significant miRNA-mediated transcriptional changes in the eye.
- Dysregulated miRNAs play a crucial role in COVID-19-associated neuro-ophthalmological conditions.
- Further research is needed to elucidate molecular changes for better COVID-19 understanding.
Related Concept Videos
MicroRNAs
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Small interfering RNAs (siRNA)
Experimental RNAi
Leaky Scanning

